The purpose of this feasibility study is to test a new treatment for preventing childbirth-related mental illness in postpartum mothers. The treatment is aimed at enhancing maternal bonding and reducing postpartum depression (PPD) and posttraumatic stress symptoms in mothers at risk. To this end, the investigators will test the clinical utility of intranasal oxytocin (IN-OXT) administered to mothers during the first postpartum days.